Related references
Note: Only part of the references are listed.The hunting of targets: challenge in miRNA research
F. Akbari Moqadam et al.
LEUKEMIA (2013)
Widespread inference of weighted microRNA-mediated gene regulation in cancer transcriptome analysis
Hiroshi I. Suzuki et al.
NUCLEIC ACIDS RESEARCH (2013)
Polycomb-Mediated Loss of miR-31 Activates NIK-Dependent NF-κB Pathway in Adult T Cell Leukemia and Other Cancers
Makoto Yamagishi et al.
CANCER CELL (2012)
MicroRNAs in acute leukemia: from biological players to clinical contributors
D. Schotte et al.
LEUKEMIA (2012)
A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
Kim J. Png et al.
NATURE (2012)
MicroRNA profiling: approaches and considerations
Colin C. Pritchard et al.
NATURE REVIEWS GENETICS (2012)
Comparison of Microarray Platforms for Measuring Differential MicroRNA Expression in Paired Normal/Cancer Colon Tissues
Maurizio Callari et al.
PLOS ONE (2012)
MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression
Cecile Desjobert et al.
BLOOD (2011)
miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma
Hironori Matsuyama et al.
BLOOD (2011)
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)
Ulrik Ralfkiaer et al.
BLOOD (2011)
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
Javeed Iqbal et al.
BLOOD (2010)
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma
Olaf Merkel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner
Yu-Xin Cui et al.
BLOOD (2009)
Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets
Pier Paolo Piccaluga et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
A specific PP2A regulatory subunit, B56γ, mediates DNA damage-induced dephosphorylation of p53 at Thr55
Heng-Hong Li et al.
EMBO JOURNAL (2007)